Digital PCR Technology and Market - The absolute quantitation segment is currently valued at approximately $600 million[20] - The targeted sequencing segment is valued at approximately $2.4 billion[23] - The relative quantitation segment is valued at approximately $2.7 billion[25] - Bio-Rad maintains a catalog of over 490,000 assays for the research community[34, 42] - Bio-Rad has over 12,000 clinical and research publications related to Digital PCR[12, 42] Bio-Rad's Digital PCR Portfolio and Assays - Bio-Rad has over 12,500 validated copy number assays[36] - Bio-Rad has over 34,000 validated mutation detection assays[36] - Bio-Rad has over 445,000 validated gene expression assays[36] - Bio-Rad has over 50 infectious disease assays[36] - Bio-Rad has over 60 validated assays for cell & gene therapy[36]